Method for reducing the risk of a cardiovascular event with conjugated antisense compounds targeting apo(a)
US-2026049310-A1 · Feb 19, 2026 · US
Shao Qing is listed as an inventor on 14 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Shao Qing |
| Total patents | 14 |
| First publication | Mar 28, 2019 |
| Latest publication | Feb 19, 2026 |
Publications ranked by popularity score, then publication date.
US-2026049310-A1 · Feb 19, 2026 · US
US-2026035763-A1 · Feb 5, 2026 · US
US-12487167-B2 · Dec 2, 2025 · US
US-2025334501-A1 · Oct 30, 2025 · US
US-2025275146-A1 · Aug 28, 2025 · US
US-12209948-B2 · Jan 28, 2025 · US
US-11932557-B2 · Mar 19, 2024 · US
US-2023168178-A1 · Jun 1, 2023 · US
US-2021403346-A1 · Dec 30, 2021 · US
US-2021395737-A1 · Dec 23, 2021 · US
Latest publications not already listed above.
US-10952989-B2 · Mar 23, 2021 · US
US-2020121639-A1 · Apr 23, 2020 · US
US-2019393673-A1 · Dec 26, 2019 · US
US-2019094123-A1 · Mar 28, 2019 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Novartis Ag | 4 |
| Cytek Biosciences Inc | 4 |
| Univ Kentucky Res Found | 3 |
| Becton Dickinson Co | 2 |
| Western Digital Tech Inc | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| G01N2015/1006 | 6 |
| G01N15/1434 | 5 |
| G01N15/01 | 5 |
| G01N2015/1493 | 4 |
| G01N2015/1438 | 4 |